✦ LIBER ✦

P281 Randomized phase II trial of adjuvant vinorelbine and epirubicin versus adriamycin and cyclophosphamide in node negative breast cancer [AViEN trial]

✍ Scribed by K.S. Kim; S.Y. Kang; R.M. Kim; S.-H. Jung; B.W. Chung; J.-W. Bae; H.J. Shin; S.-Y. Kim; Y.S. Jung; S.W. Han

Book ID: 114316620
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 53 KB
Volume: 20
Category: Article
ISSN: 0960-9776
DOI: 10.1016/s0960-9776(11)70223-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of cyclophosphamide, ep

A phase II trial of cyclophosphamide, epirubicin and vinorelbine in the treatment of advanced breast cancer

✍ E. Esteban; González de Sande; J. Puertas; J. Fra; I. Palacio; J.M. Vieitez; J.L 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 55 KB

Rationale and Design of a Phase III Tria

Rationale and Design of a Phase III Trial of Adjuvant Sequential Epirubicin/Cyclophosphamide and Taxane Versus Concurrent Epirubicin/Taxane in Operable Node-Positive Breast Cancer

✍ Edith A. Perez 📂 Article 📅 2000 🏛 CIG Media Group, LP. 🌐 English ⚖ 116 KB

Randomized phase III trial of adjuvant e

Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1–3 node-positive rapidly proliferating breast cancer

✍ Dino Amadori; Rosella Silvestrini; Mario De Lena; Francesco Boccardo; Andrea Roc 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 485 KB

Phase I/II Trial of Adjuvant Dose-Dense

Phase I/II Trial of Adjuvant Dose-Dense Docetaxel/Epirubicin/Cyclophosphamide (TEC) in Stage II and III Breast Cancer

✍ Susan Burdette-Radoux; Marie E. Wood; Julie J. Olin; Rebecca S. Laughlin; Abigai 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 463 KB

Phase II trial of high-dose epirubicin a

Phase II trial of high-dose epirubicin and cyclophosphamide in advanced breast cancer

✍ Scinto, A.F; Cercato, M.C; Botti, C; Tonachella, R; Ferraresi, V; Del Bianco, S; 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 554 KB

Phase I trial of adjuvant chemotherapy w

Phase I trial of adjuvant chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil (CEF) for stage II breast cancer

✍ Stephen E. Jones; Robert G. Mennel; George N. Peters; Mary Alice Westrick; Barry 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 263 KB

Epirubicin is a new anthracycline with a potentially more favorable toxicity profile than the parent compound, doxorubicin. Accordingly, the feasibility and toxicity of 6 courses of adjuvant chemotherapy with cyclophosphamide (C), epirubicin (E), and 5-fluorouracil (F) were assessed in 10 patients w